Purple Innovation, Inc.
0.8436-0.02 (-2.25%)
Oct 29, 4:00:01 PM EDT · NasdaqGS · PRPL · USD
Key Stats
Market Cap
91.31MP/E (TTM)
-Basic EPS (TTM)
-0.78Dividend Yield
0%Recent Filings
8-K
Regains Nasdaq bid price compliance
Purple Innovation regained Nasdaq compliance on September 8, 2025, after its stock bid price met the $1.00 minimum for ten straight business days from August 22 to September 5. This lifts the prior April 4 deficiency notice under Listing Rule 5450(a)(1). Compliance secured. The move stabilizes listing status amid ongoing market pressures.
8-K
Purple amends exec agreements
Purple Innovation amended CEO Robert DeMartini's employment agreement and RSU grants for senior leaders like CFO Todd Vogensen on August 7, 2025, tightening the 'change in control' definition to exclude acquisitions by Coliseum Capital while accelerating full vesting on termination without cause or in a control event. This sharpens executive incentives amid ownership shifts. No financial impacts disclosed. Executives gain stronger protections.
10-Q
Q2 FY2025 results
Purple Innovation's Q2 revenue fell 12.6% y/y to $105.1M, with gross profit dropping 23.0% to $37.7M and margins contracting to 35.9% from 40.7%, driven by Rejuvenate 2.0 launch delays, tariff hikes, and restructuring costs from consolidating Utah plants into Georgia—yet operating loss narrowed slightly to $14.2M thanks to 18.2% lower opex from ad efficiency and headcount cuts. Wholesale revenue, 44% of total, declined 13.4% y/y amid softer demand, while e-commerce and showrooms each dipped over 11%. Cash climbed to $34.2M after $39M in related-party debt draws, supporting liquidity through 2026 maturity, though warrants swung to a $4.4M gain. Net loss widened to $17.3M, or $(0.16) diluted EPS on 108.2M shares—consistent with calculations. Restructuring nears completion with $0.9M more charges ahead. Tariff volatility poses ongoing margin risks.
8-K
Q2 revenue dips, guidance holds
Purple Innovation reported Q2 2025 net revenue of $105.1 million, down 12.6% from $120.3 million last year, due to Rejuvenate 2.0 shipment delays and ecommerce softness, yet gross margin dipped to 35.9% from tariff costs and launch ramps. Operating expenses fell 18.2% to $51.9 million via cost controls, narrowing adjusted EBITDA loss to $(2.4) million from $(4.1) million. Strong Rejuvenate 2.0 demand doubled prior launches; the company reaffirms 2025 guidance of $465-485 million revenue and flat to $10 million adjusted EBITDA. Demand outpaces supply.
8-K
Bonus amendments defer payments
Purple Innovation amended special recognition bonuses for CEO Robert DeMartini, CFO Todd Vogensen, and COO Eric Haynor, deferring 65% of August 2025 payments to January 2026 while boosting that portion by 15% to $444,763, $392,438, and $326,214 respectively, contingent on continued service or change in control. This eases short-term cash outflow yet ties executive retention to performance through mid-2026. Executives stay vested.
IPO
Website
Employees
Sector
Industry
CRWS
Crown Crafts, Inc.
2.91+0.00
FLXS
Flexsteel Industries, Inc.
34.86-1.16
LEG
Leggett & Platt, Incorporated
10.06-0.53
LUVU
Luvu Brands, Inc.
0.04+0.00
LZB
La-Z-Boy Incorporated
32.31-0.95
NVFY
Nova Lifestyle, Inc
5.64-0.09
SGI
Somnigroup International Inc.
81.73-1.37
SN
SharkNinja, Inc.
95.51-1.65
SNBR
Sleep Number Corporation
5.52-0.54
VIOT
Viomi Technology Co., Ltd
3.08+0.25